Tandem Diabetes Care, Inc. (TNDM)
TNDM Stock Price Chart
Explore Tandem Diabetes Care, Inc. interactive price chart. Choose custom timeframes to analyze TNDM price movements and trends.
TNDM Company Profile
Discover essential business fundamentals and corporate details for Tandem Diabetes Care, Inc. (TNDM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
14 Nov 2013
Employees
2.65K
Website
https://www.tandemdiabetes.comCEO
John F. Sheridan
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
TNDM Financial Timeline
Browse a chronological timeline of Tandem Diabetes Care, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is -$0.32, while revenue estimate is $236.40M.
Earnings released on 6 Aug 2025
EPS came in at -$0.48 falling short of the estimated -$0.40 by -20.00%, while revenue for the quarter reached $240.68M , missing expectations by -3.81%.
Earnings released on 30 Apr 2025
EPS came in at -$0.67 falling short of the estimated -$0.60 by -11.67%, while revenue for the quarter reached $234.42M , beating expectations by +6.45%.
Earnings released on 26 Feb 2025
EPS came in at -$0.44 falling short of the estimated -$0.25 by -76.00%, while revenue for the quarter reached $282.65M , beating expectations by +12.43%.
Earnings released on 6 Nov 2024
EPS came in at -$0.36 surpassing the estimated -$0.43 by +16.28%, while revenue for the quarter reached $363.29M , beating expectations by +44.45%.
Earnings released on 1 Aug 2024
EPS came in at -$0.47 surpassing the estimated -$0.54 by +12.96%, while revenue for the quarter reached $221.91M , beating expectations by +8.30%.
Earnings released on 2 May 2024
EPS came in at -$0.63 surpassing the estimated -$0.80 by +21.25%, while revenue for the quarter reached $191.67M , beating expectations by +10.14%.
Earnings released on 21 Feb 2024
EPS came in at -$0.27 falling short of the estimated -$0.23 by -17.39%, while revenue for the quarter reached $196.80M , missing expectations by -2.94%.
Earnings released on 1 Nov 2023
EPS came in at -$0.38 falling short of the estimated -$0.35 by -8.57%, while revenue for the quarter reached $185.62M , missing expectations by -3.68%.
Earnings released on 3 Aug 2023
EPS came in at -$0.30 surpassing the estimated -$0.54 by +44.44%, while revenue for the quarter reached $195.92M , missing expectations by -0.73%.
Earnings released on 3 May 2023
EPS came in at -$0.63 falling short of the estimated -$0.56 by -12.50%, while revenue for the quarter reached $169.38M , missing expectations by -0.50%.
Earnings released on 22 Feb 2023
EPS came in at -$0.01 falling short of the estimated -$0.00 by -338.60%, while revenue for the quarter reached $220.50M , missing expectations by -0.23%.
Earnings released on 2 Nov 2022
EPS came in at -$0.27 falling short of the estimated -$0.05 by -455.33%, while revenue for the quarter reached $204.55M , missing expectations by -1.47%.
Earnings released on 3 Aug 2022
EPS came in at -$0.24 falling short of the estimated -$0.02 by -1.46K%, while revenue for the quarter reached $200.26M , missing expectations by -2.41%.
Earnings released on 4 May 2022
EPS came in at -$0.23 falling short of the estimated -$0.07 by -228.57%, while revenue for the quarter reached $175.91M , beating expectations by +4.57%.
Earnings released on 22 Feb 2022
EPS came in at $0.16 falling short of the estimated $0.21 by -23.81%, while revenue for the quarter reached $210.00M , beating expectations by +5.52%.
Earnings released on 3 Nov 2021
EPS came in at $0.09 surpassing the estimated $0.06 by +50.00%, while revenue for the quarter reached $179.63M , beating expectations by +33.33%.
Earnings released on 4 Aug 2021
EPS came in at $0.06 surpassing the estimated -$0.08 by +175.00%, while revenue for the quarter reached $172.14M , beating expectations by +20.07%.
Earnings released on 5 May 2021
EPS came in at -$0.07 surpassing the estimated -$0.15 by +53.33%, while revenue for the quarter reached $141.04M , beating expectations by +16.04%.
Earnings released on 24 Feb 2021
EPS came in at $0.22 surpassing the estimated $0.12 by +83.33%, while revenue for the quarter reached $168.07M , beating expectations by +7.74%.
Earnings released on 5 Nov 2020
EPS came in at -$0.09 falling short of the estimated -$0.08 by -12.50%, while revenue for the quarter reached $123.60M , beating expectations by +50.00%.
TNDM Stock Performance
Access detailed TNDM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.